Stockscreener 앱 받기
2.80
3.32%
0.09
시간 외 거래:
2.80
전일 마감가:
$2.71
열려 있는:
$2.74
하루 거래량:
2.24M
Relative Volume:
19.91
시가총액:
$91.95M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$2.59
$2.87
1주일 범위
$2.59
$3.03
52주 변동 폭
$2.59
$3.03
Lite Strategy Inc Stock (LITS) Company Profile
명칭
Lite Strategy Inc
전화
858-369-7100
주소
11455 EL CAMINO REAL, SAN DIEGO
LITS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LITS
Lite Strategy Inc
|
2.80 | 88.99M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Lite Strategy Inc Stock (LITS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-23 | 다운그레이드 | Laidlaw | Buy → Hold |
| 2022-03-25 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-03-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-03-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-02-03 | 개시 | Jefferies | Buy |
| 2020-09-22 | 개시 | Alliance Global Partners | Buy |
| 2020-05-29 | 개시 | SunTrust | Buy |
| 2018-12-20 | 개시 | H.C. Wainwright | Buy |
| 2018-07-27 | 업그레이드 | Stifel | Hold → Buy |
| 2018-07-13 | 개시 | SunTrust | Buy |
| 2016-04-18 | 재확인 | Wedbush | Neutral |
| 2015-03-23 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2014-12-18 | 재확인 | ROTH Capital | Buy |
| 2014-10-16 | 재확인 | ROTH Capital | Buy |
| 2014-07-08 | 재개 | Brean Capital | Buy |
| 2013-10-22 | 재확인 | Stifel | Buy |
| 2013-04-15 | 개시 | Stifel | Buy |
모두보기
Lite Strategy Inc 주식(LITS)의 최신 뉴스
MEI PHARMA, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) - MarketScreener
Lite Strategy: From Biotech To Litecoin Treasury (NASDAQ:LITS) - Seeking Alpha
Lite Strategy Investor Exercises Warrants in Cashless Deal - TipRanks
Lite Strategy with New NASDAQ Ticker ‘LITS’ Enters the Public Market - CryptoNinjas
LITS Stock Price and Chart — NASDAQ:LITS - TradingView
MEI Pharma, Inc will Change its Name to Lite Strategy, Inc - MarketScreener
MEI Pharma Rebrands to Lite Strategy, Inc. - TipRanks
MEI Pharma rebrands as Lite Strategy, adopts Litecoin as treasury asset - Investing.com
MEI Pharma rebrands as Lite Strategy, adopts Litecoin as treasury asset By Investing.com - Investing.com Nigeria
MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS’ - Business Wire
Lite Access Technologies Expands Through Strategic Acquisition of Ironman - MSN
MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising - Business Wire
MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange - Business Wire
Biotech Pioneer Converts $100M Treasury to Litecoin as Charlie Lee Joins Board - Stock Titan
Damon CEO Showcases Asset-Light Strategy, HyperSport Development, and Revolutionary Damon™ I/O Platform in WebBikeWorld Feature Article - Yahoo Finance
NUBURU Stockholders Green-Light Strategy to Finance Transformation in Key Stockholder Vote - Yahoo Finance
Lennar De-Risking Portfolio Through Strategic Shift - Forbes
Clorox's Innovations on Track: Kingsford & Miller Lite Bring Beercoal - Yahoo Finance
MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position - Business Wire
Navigating Retail and Specialty Lite Success: How Your Pharmacy Strategy Impacts Brand Performance - Fierce Pharma
Centurion Corp Poised for Continued Growth with Expanding Pipeline and Asset-Light Strategy - Minichart
From ‘Aisle to Algorithm': David's Bridal Unveils Digital-First Transformation to Become Wedding Industry's Leading Retailer and Media & Planning Marketplace - Newswire.com
Focus on an ‘asset-light’ strategy reason why Melco Resorts considers options for City of Dreams Manila: Lawrence Ho - GGRAsia
Sharp advances asset-light strategy with US$159.06 million sale to Sekisui Chemical - digitimes
Is CapitaLand’s Asset-Light Strategy Losing Its Shine? - Minichart
Lite Bite Foods in talks to sell minor stake to strategic investors - The Economic Times
Lennar: A Solid Investment With Its Land-Light Strategy - Seeking Alpha
MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position - MarketScreener
How asset-light business models can boost financial performance - EY
Jim Cramer on Starbucks Corporation (SBUX): ‘Will Starbucks Adopt A So-Called China Lite Strategy Under New CEO Brian Niccol?’ - Yahoo Finance
MEI Pharma Reports Fiscal Year End 2024 Cash Position - Business Wire
MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives - MarketScreener
An Post: New Green Light 2028 strategy will grow company to a €1bn business - Post & Parcel
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP) - MarketScreener
High-end hotels and asset light model suit Hyatt strategy - Hospitality Investor
By Light Announces Strategic Market Expansion into the United Kingdom - Send2Press
Minor uses asset-light strategy - bangkokpost.com
MEI Pharma, Inc. Announces Board Changes - MarketScreener
MEI Pharma Announces Results of Special Meeting of Stockholders - MarketScreener
MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals - MarketScreener
Mei Pharma, Inc. Announces Executive Changes - MarketScreener
MEI Pharma, Inc. Announces Executive Changes - MarketScreener
MEI Pharma Announces 1-for-20 Reverse Stock Split - Business Wire
MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates - MarketScreener
MEI PHARMA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) - MarketScreener
MEI Pharma, Inc. Announces Not Stand for Re-Election of Directors - MarketScreener
MEI Pharma and Kyowa Kirin Report Clinical Data on Zandelisib at European Hematology Association 2022 Hybrid Congress - MarketScreener
MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2022 - MarketScreener
MEI Pharma Strengthens Clinical and Quality Expertise with New Key Executive Appointments - MarketScreener
CANOmni-Lite Industries Announces Strategic Acquisition of Designed Precision Castings Following the Completion of the Sale and Leaseback of the Company’s California Real Estate Assets - foundry-planet.com
MEI Pharma : January 2022 Corporate Presentation - MarketScreener
Lite Strategy Inc (LITS) 재무 분석
Lite Strategy Inc (LITS)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.43%
0.09%
자본화:
|
볼륨(24시간):